Document:

Exhibit 4.4

 

WARRANT AGREEMENT

 

This Warrant Agreement (“Warrant Agreement”)
is made as of [●], 2021, by and between Chardan NexTech Acquisition Corp., a Delaware corporation (the “Company”),
and Continental Stock Transfer & Trust Company (the “Warrant Agent”).

 

WHEREAS, the Company is engaged in a public offering
(the “Public Offering”) of 15,000,000 units (the “Units”) of the Company (and up to 2,250,000 additional
Units if the underwriters’ over-allotment option is exercised in full), each Unit consisting of one share of common stock, par value
$0.0001 per share (the “Common Stock”) and one warrant (each whole warrant, a “Public Warrant”),
each Public Warrant entitling its holder to purchase one share of Common Stock (the “Public Warrant Shares”);

 

WHEREAS, the Company has received a binding commitment
from Chardan NexTech Warrant Holdings LLC (“Holdings”), to purchase up to 5,599,956 private placement warrants (the
“Private Warrants,” together with the Public Warrants, the “Warrants”) pursuant the Subscription
Agreement, dated as of [●], 2021 (“Subscription Agreement”), and in connection therewith, will issue and deliver
up to 5,599,956 Private Warrants, each Private Warrant entitling its holder to purchase one share of Common Stock (together with the Public
Warrant Shares, the “Warrant Shares”); and

 

WHEREAS, the Company may issue additional warrants
to purchase shares of Common Stock hereafter from time to time which shall have the same terms and be in the same form as the Private
Warrants; and

 

WHEREAS, the Company has filed with the Securities
and Exchange Commission (the “SEC”) a Registration Statement on Form S-1, No. 333-253958, as amended (the “Registration
Statement”), for the registration, under the Securities Act of 1933, as amended (the “Act”) of, among other
securities, the Public Warrants;

 

WHEREAS, the Company desires the Warrant Agent
to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer,
exchange, redemption and exercise of the Warrants;

 

WHEREAS, the Company desires to provide for the
form, terms and provisions of the Warrants, including the terms upon which they shall be issued and exercised, and the respective rights,
limitation of rights and immunities of the Company, the Warrant Agent and the holders of the Warrants; and

 

WHEREAS, all acts and things have been done and
performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant
Agent, as provided herein, the legally valid and binding obligations of the Company, and to authorize the execution and delivery of this
Warrant Agreement.

 

NOW, THEREFORE, in consideration of the mutual
agreements herein contained, the parties hereto agree as follows:

 

1. Appointment of Warrant Agent. The Company
hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such appointment
and agrees to perform the same in accordance with the terms and conditions set forth in this Warrant Agreement.

 

2. Warrants.

 

2.1 Form of Warrant.
Each Public Warrant shall be: (a) issued in registered form only, (b) in substantially the form of Exhibit A hereto, the provisions
of which are incorporated herein and (c) signed by, or bear the facsimile signature of, the Chairman of the Board, the Chief Executive
Officer or the Chief Financial Officer of the Company. In the event the person whose facsimile signature has been placed upon any Warrant
shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with
the same effect as if he or she had not ceased to be such at the date of issuance.

 

     

     

    

 

2.2 Effect of Countersignature.
Unless and until countersigned by the Warrant Agent pursuant to this Warrant Agreement, a Warrant shall be invalid and of no effect and
may not be exercised by the holder thereof.

 

2.3 Registration.

  

2.3.1 Warrant Register.
The Warrant Agent shall maintain books (the “Warrant Register”), for the registration of the original issuance and
transfers of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the names
of the respective holders thereof in such denominations and otherwise in accordance with instructions delivered to the Warrant Agent by
the Company.

 

2.3.2 Registered Holder.
Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person
in whose name such Warrant shall be registered upon the Warrant Register (“Registered Holder”) as the absolute owner
of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other writing on the Warrant certificate
made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and
neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

2.4 Detachability of Warrants.
Each of the Common Stock and the Public Warrants comprising the Units will begin to trade separately on (i) the 90th day after the effectiveness
of the Registration Statement, or (ii) such earlier date as Chardan Capital Markets, LLC, as representative of the underwriters (the “Representative”),
shall determine is acceptable (such date, the “Detachment Date”). In no event will separate trading of the securities
comprising the Units commence until the Company (i) files a Current Report on Form 8-K with the SEC including audited balance sheet reflecting
the Company’s receipt of the gross proceeds of the Public Offering and (ii) issues a press release announcing when such separate
trading will begin.

 

2.5 Private Warrants.
The Private Warrants will be issued substantially in the form of Exhibit B hereto, and they (i) will be exercisable either for
cash or on a cashless basis at the holder’s option pursuant to Section 3.3 hereof and (ii) will not be redeemable by the
Company, in either case as long as the Private Warrants are held by the initial purchasers or any of their permitted transferees (as prescribed
in the Subscription Agreement). The Private Warrants may not be sold, transferred, assigned, pledged or hypothecated, or be the subject
of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of, the Private
Warrants (or any securities underlying the Private Warrants) for a period of 180 days following the effective date of the Registration
Statement to anyone other than any member participating in the Public Offering and the officers or partners thereof, if all securities
so transferred remain subject to the lock-up restriction set forth above for the remainder of the time period.

 

3. Terms and Exercise of Warrants.

 

3.1 Warrant Price.
Each Warrant shall, when countersigned by the Warrant Agent, entitle the Registered Holder thereof, subject to the provisions of such
Warrant and of this Warrant Agreement, to purchase from the Company the number of shares of Common Stock stated therein, at $11.50 per
whole share, subject to the adjustments provided in Section 4 hereof. The term “Warrant Price” as used in this
Warrant Agreement refers to the price per whole share at which shares of Common Stock may be purchased at the time such Warrant is exercised.
The Public Warrants may only be exercised for a whole number of Warrant Shares by a Registered Holder. No fractional shares will be issued.

 

3.2 Duration of Warrants.
A Warrant may be exercised only during the period (“Exercise Period”) commencing 30 days after the completion of the
Company’s initial business combination and terminating at 5:00 p.m., New York City time, on the earlier to occur of (i) (A) five
years following the completion of the Company’s initial business combination with respect to the Public Warrants, and (B) five years
from the effective date of the Registration Statement with respect to the Private Warrants purchased by Holdings, provided that
once the Private Warrants are not beneficially owned, directly or indirectly, by Chardan Capital Markets, LLC or any of its related persons
anymore, the Private Warrants may not be exercised five years following the completion of the Company’s initial business combination,
and (ii) the date fixed for redemption of the Warrants as provided in Section 6 of this Warrant Agreement (“Expiration
Date”). Except with respect to the right to receive the Redemption Price (as set forth in Section 6 hereunder), each
Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof
under this Warrant Agreement shall cease at the close of business on the Expiration Date. The Company may extend the duration of the Warrants
by delaying the Expiration Date; provided, however, that the Company (i) may not extend the duration of the Private Warrants by delaying
the Expiration Date and (ii) will provide written notice of not less than 20 days to Registered Holders of such extension and that such
extension shall be identical in duration among all of the then outstanding Warrants.

 

    2

     

    

 

3.3 Exercise of Warrants.

 

3.3.1 Cash Exercise.
Subject to the provisions of the Warrant and this Warrant Agreement, a Warrant, when countersigned by the Company, may be exercised by
the Registered Holder thereof by surrendering it at the office of the Warrant Agent, or at the office of its successor as Warrant Agent,
currently being:

 

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, New York 10004

Attn: Compliance Department

 

with the subscription form, as set forth in the
Warrant, duly executed, and by paying in full, in lawful money of the United States, by certified or bank cashier’s check payable
to the order of the Warrant Agent or by wire transfer to the Warrant Agent’s bank account, the Warrant Price for each whole Warrant
Share as to which the Warrant is exercised and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange
of the Warrant for the Warrant Shares, and the issuance of the Warrant Shares (such exercise, a “Cash Exercise”). A
Cash Exercise in accordance with this Section 3.3.1 is available to the Registered Holder only during such times that there is
an effective registration statement registering the Warrant Shares, with the prospectus contained therein being available for the resale
of the Warrant Shares.

 

3.3.2 Cashless Exercise.
Subject to Section 2.4, notwithstanding anything contained herein to the contrary, if there is no effective registration statement
registering the Warrant Shares on any day the Registered Holder desires to exercise the Warrants and more than 120 days have passed since
the Company complete its initial business combination, the Registered Holder may exercise the Warrants in whole or in part in lieu of
making a cash payment for whole numbers of Warrant Shares, by providing notice to the Chief Financial Officer of the Company in a subscription
form of its election to utilize cashless exercise, in which event the Company shall issue to the Registered Holder the number of Warrant
Shares determined as follows:

 

X = Y [(A-B)/A]

 

where:

 

X = the number of Warrant Shares to be issued to the Registered
Holder.

 

Y = the number of Warrant Shares with respect to which this
Warrant is being exercised.

 

A = the fair market value of one share of Common Stock.

 

B = the Warrant Price.

 

The Registered Holder may not exercise any Warrants
in the absence of a registration statement except pursuant to this Section 3.3.2. For purposes of this Section 3.3.2 and
Section 4.1, the fair market value of one share of Common Stock is defined as follows:

 

(i) if the Company’s shares of
Common Stock are listed and traded on the New York Stock Exchange, the NYSE American, the NASDAQ Global Select Market, or the NASDAQ Global
Market (each, a “Trading Market”), the fair market value shall be deemed to be the average of the closing price on
such Trading Market for the 10 trading day ending on the third trading day immediately prior to the date the subscription form is submitted
to the Company in connection with the exercise of the Warrant; or

 

(ii) if the Company’s shares of
Common Stock are not listed on a Trading Market, but is traded in the over-the-counter market, the fair market value shall be deemed to
be the average of the bid price on such Trading Market for the 10 trading days ending on the third trading day immediately prior to the
date the subscription form is submitted in connection with the exercise of the Warrant; or

 

(iii) if there is no active public market
for the Company’s shares of Common Stock, the fair market value of the shares of Common Stock shall be determined in good faith
by the Company’s board of directors.

 

    3

     

    

 

3.3.3 Fractional Shares.
Notwithstanding any provision to the contrary contained in this Warrant Agreement, the Company shall not be required to issue any fraction
of a Warrant Share in connection with the exercise of Warrants, and in any case where the Registered Holder would be entitled under the
terms of the Warrants to receive a fraction of a Warrant Share upon the exercise of such Registered Holder’s Warrants, issue or
cause to be issued only the largest whole number of Warrant Shares issuable on such exercise (and such fraction of a Warrant Share will
be disregarded); provided, that if more than one Warrant certificate is presented for exercise at the same time by the same Registered
Holder, the number of whole Warrant Shares which shall be issuable upon the exercise thereof shall be computed on the basis of the aggregate
number of Warrant Shares issuable on exercise of all such Warrants.

 

3.3.4 Issuance of Certificates.
No later than three (3) business days following the exercise of any Warrant and the clearance of the funds in payment of the Warrant
Price pursuant to Section 3.3.1 or cashless exercise pursuant to Section 3.3.2, the Company shall issue, or cause to be
issued, to the Registered Holder of such Warrant a certificate or certificates representing (or at the option of the Registered Holder,
deliver electronically through the facilities of the Depository Trust Corporation) the number of full shares of Common Stock to which
he, she or it is entitled, registered in such name or names as may be directed by him, her or it, and, if such Warrant shall not have
been exercised or surrendered in full, a new countersigned Warrant for the number of shares as to which such Warrant shall not have been
exercised or surrendered. Notwithstanding the foregoing, the Company shall not deliver, or cause to be delivered, any securities without
applicable restrictive legend pursuant to the exercise of a Warrant unless (a) a registration statement under the Act with respect to
the shares of Common Stock issuable upon exercise of such Warrants is effective and a current prospectus relating to the shares of Common
Stock issuable upon exercise of the Warrants is available for delivery to the Registered Holder of the Warrant or (b) in the opinion
of counsel to the Company, the exercise of the Warrants is exempt from the registration requirements of the Act and such securities are
qualified for sale or exempt from qualification under applicable securities laws of the states or other jurisdictions in which the Registered
Holder resides. Warrants may not be exercised by, or securities issued to, any Registered Holder in any state in which such exercise
or issuance would be unlawful. In addition, in no event will the Company be obligated to pay such Registered Holder any cash consideration
upon exercise or otherwise “net cash settle” the Warrant.

 

3.3.5 Valid Issuance.
All shares of Common Stock issued upon the proper exercise or surrender of a Warrant in conformity with this Warrant Agreement shall be
validly issued, fully paid and non-assessable.

 

3.3.6 Date of Issuance.
Each person or entity in whose name any such certificate for shares of Common Stock is issued shall, for all purposes, be deemed to have
become the holder of record of such shares on the date on which the Warrant was surrendered and payment of the Warrant Price was made,
irrespective of the date of delivery of such certificate, except that, if the date of such surrender and payment is a date when the stock
transfer books of the Company are closed, such person shall be deemed to have become the holder of such shares at the close of business
on the next succeeding date on which the stock transfer books are open.

 

3.3.7 Maximum Percentage.
A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions contained in this Section
3.3.7; however, no holder of a Warrant shall be subject to this Section 3.3.7 unless he, she or it makes such election. If
the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s Warrant, and such holder shall
not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person (together with such
person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess of 9.99% (the “Maximum
Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the
foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such person and its affiliates shall include
the number of shares of Common Stock issuable upon exercise of the Warrant with respect to which the determination of such sentence is
being made, but shall exclude the shares of Common Stock that would be issuable upon (x) exercise of the remaining, unexercised portion
of the Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion of the unexercised or unconverted portion
of any other securities of the Company beneficially owned by such person and its affiliates (including, without limitation, any convertible
notes or convertible preferred shares or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained
herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance
with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant,
in determining the number of outstanding shares of Common Stock, the holder may rely on the number of outstanding shares of Common Stock
as reflected in (1) the Company’s most recent annual report on Form 10-K, quarterly report on Form 10-Q, current report on Form
8-K or other public filing with the SEC as the case may be, (2) a more recent public announcement by the Company, or (3) any other notice
by the Company or the Warrant Agent setting forth the number of shares of Common Stock outstanding. For any reason at any time, upon the
written request of the holder of the Warrant, the Company shall, within two (2) business days, confirm orally and in writing to such holder
the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of equity securities of the Company by the holder and its affiliates since the date
as of which such number of outstanding shares of Common Stock was reported. By written notice to the Company, the holder of a Warrant
may from time to time increase or decrease the Maximum Percentage applicable to such holder to any other percentage specified in such
notice; provided, however, that any such increase shall not be effective until the sixty-first (61st) day after such notice is delivered
to the Company.

 

    4

     

    

 

4. Adjustments.

 

4.1 Stock Dividends, Splits.
If, after the date hereof, and subject to the provisions of Section 4.5 below, the number of outstanding shares of Common Stock
is increased by a stock dividend payable in shares of Common Stock, or by a forward or reverse split of shares of Common Stock, or other
similar event, then, on the effective date of such stock dividend, split or similar event, the number of shares of Common Stock issuable
on exercise of each Warrant shall be increased or decreased in proportion to such increase or decrease in outstanding shares of Common
Stock. A rights offering to all holders of the shares of Common Stock entitling holders to purchase shares of Common Stock at a price
less than the fair market value shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the
number of shares of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights
offering that are convertible into or exercisable for the shares of Common Stock) multiplied by (ii) one (1) minus the quotient of (x)
the price per share of Common Stock paid in such rights offering divided by (y) the fair market value. For purposes of this subsection
4.1, if the rights offering is for securities convertible into or exercisable for shares of Common Stock, in determining the price payable
for the shares of Common Stock, there shall be taken into account any consideration received for such rights, as well as any additional
amount payable upon exercise or conversion.

 

4.2 Aggregation of Shares.
If, after the date hereof, and subject to the provisions of Section 4.5, the number of outstanding shares of Common Stock is decreased
by a consolidation, combination or reclassification of shares of Common Stock or other similar event, then, on the effective date of such
consolidation, combination, reclassification or similar event, the number of shares of Common Stock issuable on exercise of each Warrant
shall be decreased in proportion to such decrease in outstanding shares of Common Stock.

 

4.3 Extraordinary Dividends.
If the Company, at any time while the Warrants (or rights to purchase the Warrants) are outstanding and unexpired, shall pay a dividend
or make a distribution in cash, securities or other assets to the holders of the Common Stock on account of such Common Stock (or other
shares of the Company’s capital stock into which the Warrants are convertible), other than (a) as described in Section 4.1
above, (b) Ordinary Cash Dividends (as defined below), (c) to satisfy the conversion rights of the holders of the Common Stock in connection
with a proposed initial business combination or vote to extend the time period to complete an initial business combination, (d) as a result
of the repurchase of Common Stock by the Company in connection with an initial business combination or as otherwise permitted by the Investment
Management Trust Agreement between the Company and the Warrant Agent dated of even date herewith or (e) in connection with the Company’s
liquidation and the distribution of its assets upon its failure to consummate a business combination (any such non-excluded event being
referred to herein as an “Extraordinary Dividend”), then the Warrant Price shall be decreased, effective immediately
after the effective date of such Extraordinary Dividend, by the amount of cash and the fair market value (as determined by the Company’s
board of directors, in good faith) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary
Dividend. For purposes of this Section 4.3, “Ordinary Cash Dividends” means any cash dividend or cash distribution
which, when combined on a per share basis with the per share amounts of all other cash dividends and cash distributions paid on the Common
Stock during the 365-day period ending on the date of declaration of such dividend or distribution (as adjusted to appropriately reflect
any of the events referred to in other subsections of this Section 4 and excluding cash dividends or cash distributions that resulted
in an adjustment to the Warrant Price or to the number of shares of Common Stock issuable on exercise of each Warrant) does not exceed
$0.50 (being 5% of the offering price of the Units in the Public Offering). Further, the holders of the Private Warrants that are beneficially
owned by Chardan Capital Markets, LLC or any of its related persons may not receive or accrue any cash dividends prior to the exercise
or conversion of such Private Warrants, as required by FINRA Rule 5110(g)(8)(F).

 

4.4 Adjustments in Exercise
Price. Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided in Sections
4.1 and 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price, immediately
prior to such adjustment, by a fraction, (a) the numerator of which shall be the number of shares of Common Stock purchasable upon the
exercise of the Warrants immediately prior to such adjustment, and (b) the denominator of which shall be the number of shares of Common
Stock so purchasable immediately thereafter.

 

    5

     

    

 

4.5 Replacement of Securities
upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding shares of Common Stock (other than
a change covered by Sections 4.1 or 4.2 hereof or one that solely affects the par value of such shares of Common Stock),
or, in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in
which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding
shares of Common Stock), or, in the case of any sale or conveyance to another corporation or entity of the assets or other property of
the Company as an entirety or substantially as an entirety, in connection with which the Company is dissolved, the Registered Holders
shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and
in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights
represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification,
reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the Registered Holder would have
received if such Registered Holder had exercised his, her or its Warrant(s) immediately prior to such event; and if any reclassification
also results in a change in shares of Common Stock covered by Sections 4.1 or 4.2, then such adjustment shall be made pursuant to Sections
4.1, 4.2, 4.3 and this Section 4.4. The provisions of this Section 4.4 shall similarly apply to successive reclassifications, reorganizations,
mergers or consolidations, sales or other transfers.

 

4.6 Notices of Changes
in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon exercise of a Warrant, the Company shall
give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment and the increase
or decrease, if any, in the number of shares purchasable at such price upon the exercise of a Warrant, setting forth in reasonable detail
the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified in Sections
4.1 – 4.5 the Company shall give written notice to each Registered Holder, at the last address set forth for such Registered
Holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such notice, or any defect therein,
shall not affect the legality or validity of such event.

 

4.7 Form of Warrant.
The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued after such adjustment
may state the same Warrant Price and the same number of shares as is stated in the Warrants initially issued pursuant to this Warrant
Agreement. However, the Company may, at any time, in its sole discretion, make any change in the form of Warrant that the Company may
deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange
or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

 

4.8 Notice of Certain Transactions.
In the event that the Company shall (a) offer to holders of all its Common Stock rights to subscribe for or to purchase any securities
convertible into shares of Common Stock or shares of stock of any class or any other securities, rights or options, (b) issue any rights,
options or warrants entitling all the holders of Common Stock to subscribe for shares of Common Stock, or (c) make a tender offer, redemption
offer or exchange offer with respect to the Common Stock, the Company shall send to the Registered Holders a notice of such action or
offer. Such notice shall be mailed to the Registered Holders at their addresses as they appear in the Warrant Register, which shall specify
the record date for the purposes of such dividend, distribution or rights, or the date such issuance or event is to take place and the
date of participation therein by the holders of Common Stock, if any such date is to be fixed, and shall briefly indicate the effect of
such action on the Common Stock and on the number and kind of any other shares of stock and on other property, if any, and the number
of shares of Common Stock and other property, if any, issuable upon exercise of each Warrant and the Warrant Price after giving effect
to any adjustment pursuant to this Section 4 which would be required as a result of such action. Such notice shall be given as
promptly as practicable after the Company has taken any such action.

 

4.9 Issuance in Connection
with a Business Combination. If, in connection with a Business Combination, the Company (a) issues additional shares of Common Stock
or equity-linked securities for capital raising purposes at an issue price or effective issue price of less than $9.20 per share (with
such issue price or effective issue price as determined by the Company’s board of directors, in good faith), (y) the aggregate gross
proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of
the Business Combination on the date of the consummation of such Business Combination (net of redemptions), and (z) the Market Price (as
defined below) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the Market Price,
and the Redemption Trigger Price (as defined in Section 6.1 below) shall be adjusted (to the nearest cent) to be equal
to 160% of the Market Price. For purposes of this Section 4.9, the “Market Price” shall mean the volume weighted average
reported last sale price of the shares of Common Stock for the 20 trading days ending on the trading day prior to the date of the completion
of the Business Combination.

 

5. Transfer and Exchange of Warrants.

 

5.1 Transfer of Warrants.
Prior to the Detachment Date, the Warrants may be transferred or exchanged only together with the Unit in which such Warrant is included,
and only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore, each transfer of a Unit
on the register relating to such Units shall operate also to transfer the Warrants included in such Unit. From and after the Detachment
Date, this Section 5.1 will have no further force and effect.

 

5.2 Registration of Transfer.
The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant into the Warrant Register, upon surrender
of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions for transfer.
Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be
cancelled by the Warrant Agent. The Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon
the Company’s request.

 

5.3 Procedure for Surrender
of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer, and, thereupon,
the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants so surrendered,
representing an equal aggregate number of Warrants; provided, however, that, in the event a Warrant surrendered for transfer bears a restrictive
legend, the Warrant Agent shall not cancel such Warrant and shall issue new Warrants in exchange therefor until the Warrant Agent has
received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also
bear a restrictive legend.

 

    6

     

    

 

5.4 Fractional Warrants.
The Warrant Agent shall not be required to effect any registration of transfer or exchange that will result in the issuance of a Warrant
certificate for a fraction of a Warrant.

 

5.5 Service Charges.
No service charge shall be made for any exchange or registration of transfer of Warrants.

 

5.6 Warrant Execution and
Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms of this Warrant
Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required
by the Warrant Agent, will supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

 

6. Redemption.

 

6.1 Redemption. Subject
to the second sentence of this Section 6.1, all (and not less than all) of the outstanding Warrants may be redeemed, in whole and
not in part, at the option of the Company, at any time from and after the Warrants become exercisable, and prior to their expiration,
at the office of the Warrant Agent, upon the notice referred to in Section 6.2, at the price of $0.01 per Warrant (“Redemption
Price”); provided that the last reported sales price of the Common Stock has been equal to or greater than $16.00 per share
(subject to adjustment for splits, dividends, recapitalizations and other similar events) (the “Redemption Trigger Price”),
for any ten (10) trading days within a thirty (30) trading day-period ending on the third business day prior to the date on which notice
of redemption is given and provided further that there is a current registration statement in effect with respect to the shares of Common
Stock underlying the Warrants for each day in the aforementioned 30-day trading period and continuing each day thereafter until the Redemption
Date (defined below). For avoidance of doubt, if and when the Warrants become redeemable by the Company under this Section 6.1,
the Company may exercise its redemption right, even if it is unable to register or qualify the Warrant Shares for sale under all applicable
state securities laws.

 

6.2 Date Fixed for, and
Notice of, Redemption. In the event the Company shall elect to redeem all of the Warrants, the Company shall fix a date for the redemption
(the “Redemption Date”). Notice of redemption shall be mailed by first class mail, postage prepaid, by the Company
not less than 30 days prior to the date fixed for redemption to the Registered Holders of the Warrants to be redeemed at their last addresses
as they shall appear on the Warrant Register. Any notice mailed in the manner herein provided shall be conclusively presumed to have been
duly given, whether or not the Registered Holder received such notice.

 

6.3 Exercise After Notice
of Redemption. The Warrants may be exercised in accordance with Section 3 of this Warrant Agreement at any time after notice
of redemption shall have been given by the Company pursuant to Section 6.2 hereof and prior to the Redemption Date; provided that
the Company may require the Registered Holder who desires to exercise the Warrant to elect cashless exercise as set forth under Section
3.3.2, and such Registered Holder must exercise the Warrants on a cashless basis if the Company so requires. On and after the Redemption
Date, the Registered Holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Redemption
Price.

 

6.4 No Other Rights to
Cash Payment. Except for a redemption in accordance with this Section 6, no Registered Holder of any Warrant shall be entitled
to any cash payment whatsoever from the Company in connection with the ownership, exercise or surrender of any Warrant under this Warrant
Agreement.

 

7. Other Provisions Relating to Rights of Registered
Holders of Warrants.

 

7.1 No Rights as Stockholder.
A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder of the Company, including, without limitation,
the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as stockholders
in respect of the meetings of stockholders or the election of directors of the Company or any other matter.

 

7.2 Lost, Stolen Mutilated
or Destroyed Warrants. If any Warrant is lost, stolen, mutilated or destroyed, the Company and the Warrant Agent may, on such terms
as to indemnity or otherwise as they may in their discretion impose (which terms shall, in the case of a mutilated Warrant, include the
surrender thereof), issue a new Warrant of like denomination, tenor and date as the Warrant so lost, stolen, mutilated or destroyed. Any
such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated
or destroyed Warrant shall be at any time enforceable by anyone.

 

7.3 Reservation of shares
of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued shares of Common
Stock that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Warrant Agreement.

 

7.4 Registration of shares
of Common Stock. The Company agrees, it shall use its best efforts to maintain with the SEC an effective registration statement for
the registration under the Act of the shares of Common Stock issuable upon exercise of the Warrants, and a current prospectus relating
thereto, until the expiration of the Warrants in accordance with the provisions of this Warrant Agreement. In addition, the Company agrees
to use its best efforts to register the shares of Common Stock issuable upon exercise of the Warrants under state blue sky laws, to the
extent an exemption is not available.

 

8. Concerning the Warrant Agent and Other Matters.

 

8.1 Payment of Taxes.
The Company will, from time to time, promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent in respect
of the issuance or delivery of shares of Common Stock upon the exercise of Warrants, but the Company shall not be obligated to pay any
transfer taxes in respect of the Warrants or such shares.

 

    7

     

    

 

8.2 Resignation, Consolidation,
or Merger of Warrant Agent.

 

8.2.1 Appointment of Successor
Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further
duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent
becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint, in writing, a successor Warrant Agent in place
of the Warrant Agent. If the Company shall fail to make such appointment within a period of 30 days after it has been notified in writing
of such resignation or incapacity by the Warrant Agent or by the Registered Holder of the Warrant (who shall, with such notice, submit
his, her or its Warrant for inspection by the Company), then the Registered Holder of any Warrant may apply to the Supreme Court of the
State of New York for the County of New York for the appointment of a successor Warrant Agent. Any successor Warrant Agent, whether appointed
by the Company or by such court, shall be a corporation organized and existing under the laws of the State of New York, in good standing
and having its principal office in the Borough of Manhattan, City and State of New York, and be authorized under such laws to exercise
corporate trust powers and subject to supervision or examination by federal or state authorities. After appointment, any successor Warrant
Agent shall be vested with all the authority, powers, rights, immunities, duties and obligations of its predecessor Warrant Agent with
like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but, if for any reason it becomes necessary
or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to
such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and, upon request of any
successor Warrant Agent, the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and
effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties and obligations.

 

8.2.2 Notice of Successor
Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor
Warrant Agent and the transfer agent for the Common Stock not later than the effective date of any such appointment.

 

8.2.3 Merger or Consolidation
of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may be consolidated or any corporation
resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this
Warrant Agreement without any further act on the part of the Company or the Warrant Agent.

 

8.3 Fees and Expenses of
Warrant Agent.

 

8.3.1 Remuneration. The
Company agrees to pay the Warrant Agent reasonable remuneration for its services as Warrant Agent hereunder and will reimburse the Warrant
Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution of its duties hereunder.

 

8.3.2 Further Assurances.
The Company agrees to perform, execute, acknowledge and deliver, or cause to be performed, executed, acknowledged and delivered, all such
further and other acts, instruments and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing
of the provisions of this Warrant Agreement.

 

8.4 Liability of Warrant
Agent.

 

8.4.1 Reliance on Company
Statement. Whenever, in the performance of its duties under this Warrant Agreement, the Warrant Agent shall deem it necessary or desirable
that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter
(unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by
a statement signed by the Chief Executive Officer, Chief Financial Officer or Chairman of the Board of the Company and delivered to the
Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant to the provisions
of this Warrant Agreement.

 

8.4.2 Indemnity. The
Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith. The Company agrees to indemnify
the Warrant Agent and hold it harmless against any and all liabilities, including judgments, costs and reasonable counsel fees, for anything
done or omitted by the Warrant Agent in the execution of this Warrant Agreement, except as a result of the Warrant Agent’s gross
negligence, willful misconduct or bad faith.

 

8.4.3 Exclusions. The
Warrant Agent shall have no responsibility with respect to the validity of this Warrant Agreement or with respect to the validity or execution
of any Warrant (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition
contained in this Warrant Agreement or in any Warrant; nor shall it be responsible to make any adjustments required under the provisions
of Section 4 hereof or responsible for the manner, method or amount of any such adjustment or the ascertaining of the existence
of facts that would require any such adjustment; nor shall it, by any act hereunder, be deemed to make any representation or warranty
as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this Warrant Agreement or any Warrant or
as to whether any shares of Common Stock will when issued be valid and fully paid and non-assessable.

 

8.5 Acceptance of Agency.
The Warrant Agent hereby accepts the agency established by this Warrant Agreement and agrees to perform the same upon the terms and conditions
herein set forth and, among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account
for, and pay to the Company, all moneys received by the Warrant Agent for the purchase of shares of the Company’s Common Stock through
the exercise of Warrants.

 

8.6 Waiver. The Warrant
Agent hereby waives any right of set-off or any other right, title, interest or claim of any kind (“Claim”) in or to
any distribution of the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof,
by and between the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse, reimbursement, payment
or satisfaction for any Claim against the Trust Account for any reason whatsoever.

 

    8

     

    

 

9. Miscellaneous Provisions.

 

9.1 Successors. All
the covenants and provisions of this Warrant Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure
to the benefit of their respective successors and assigns.

 

9.2 Notices. Any notice,
statement or demand authorized by this Warrant Agreement to be given or made by the Warrant Agent or by the Registered Holder of any Warrant
to or on the Company shall be delivered by hand or sent by registered or certified mail or overnight courier service, addressed (until
another address is filed in writing by the Company with the Warrant Agent) as follows:

  

Chardan NexTech Acquisition Corp.

17 State Street, 21st Floor, 

New York, NY 10004

 

with a copy (which shall not constitute notice) to:

 

Reed Smith LLP

599 Lexington Avenue

New York, New York 10022

Attn: Ari Edelman, Esq.

 

Any notice, statement or demand authorized by
this Warrant Agreement to be given or made by the Registered Holder of any Warrant or by the Company to or on the Warrant Agent shall
be delivered by hand or sent by registered or certified mail or overnight courier service, addressed (until another address is filed in
writing by the Warrant Agent with the Company), as follows:

 

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, New York 10004

 

Any notice, sent pursuant to this Warrant Agreement
shall be effective, if delivered by hand, upon receipt thereof by the party to whom it is addressed, if sent by overnight courier, on
the next business day of the delivery to the courier, and if sent by registered or certified mail on the third day after registration
or certification thereof.

 

9.3 Applicable Law and
Exclusive Forum.

 

9.3.1 The validity, interpretation,
and performance of this Warrant Agreement and of the Warrants shall be governed in all respects by the laws of the State of New York,
without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction.
The Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Warrant Agreement,
including under the Securities Act, shall be brought and enforced in the courts of the State of New York or the United States District
Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive forum
for any such action, proceeding or claim. The Company hereby waives any objection to such exclusive jurisdiction and that such courts
represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph will not apply to suits brought to enforce
any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America
are the sole and exclusive forum.

 

9.3.2 Any person or entity purchasing
or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in
this Section 9.3. If any action, the subject matter of which is within the scope the forum provisions above, is filed in a
court other than a court located within the State of New York or the United States District Court for the Southern District of New York
(a “foreign action”) in the name of any Warrant holder, such Warrant holder shall be deemed to have consented to: (x)
the personal jurisdiction of the state and federal courts located within the State of New York or the United States District
Court for the Southern District of New York in connection with any action brought in any such court to enforce the forum provisions (an
“enforcement action”), and (y) having service of process made upon such Warrant holder in any such enforcement action
by service upon such Warrant holder’s counsel in the foreign action as agent for such Warrant holder.

 

Any such process or summons
to be served upon the Company or the Warrant Agent may be served by transmitting a copy thereof by registered or certified mail, return
receipt requested, postage prepaid, addressed to it at the address set forth in Section 9.2 hereof. Such mailing shall be deemed personal
service and shall be legal and binding upon the party receiving such service in any action, proceeding, or claim.

 

9.4 Persons Having Rights
under this Warrant Agreement. Nothing in this Warrant Agreement expressed and nothing that may be implied from any of the provisions
hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto and the
Registered Holders of the Warrants and, for the purposes of Sections 2.5 hereof, the Representative and the underwriters, any right,
remedy, or claim under or by reason of this Warrant Agreement or of any covenant, condition, stipulation, promise, or agreement hereof.
All covenants, conditions, stipulations, promises, and agreements contained in this Warrant Agreement shall be for the sole and exclusive
benefit of the parties hereto and their successors and assigns and of the Registered Holders of the Warrants.

 

9.5 Examination of the
Warrant Agreement. A copy of this Warrant Agreement shall be available at all reasonable times at the office of the Warrant Agent
in the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may
require any such Registered Holder to submit his, her or its Warrant for inspection.

 

    9

     

    

 

9.6 Counterparts- Facsimile
Signatures. This Warrant Agreement may be executed in any number of counterparts, and each of such counterparts shall, for all purposes,
be deemed to be an original, and all such counterparts shall together constitute one and the same instrument. Facsimile signatures shall
constitute original signatures for all purposes of this Warrant Agreement.

 

9.7 Effect of Headings.
The section headings herein are for convenience only and are not part of this Warrant Agreement and shall not affect the interpretation
thereof.

 

9.8 Amendments. This
Warrant Agreement and any Warrant certificate may be amended by the parties hereto by executing a supplemental warrant agreement, without
the consent of any of the Warrant holders, for the purpose of (i) curing any ambiguity, or curing, correcting or supplementing any defective
provision contained herein, or making any other provisions with respect to matters or questions arising under this Warrant Agreement that
is not inconsistent with the provisions of this Warrant Agreement or the Warrant certificates, (ii) evidencing the succession of another
corporation to the Company and the assumption by any such successor of the covenants of the Company contained in this Warrant Agreement
and the Warrants, (iii) evidencing and providing for the acceptance of appointment by a successor Warrant Agent with respect to the Warrants,
(iv) adding to the covenants of the Company for the benefit of the Registered Holders or surrendering any right or power conferred upon
the Company under this Warrant Agreement, or (v) amending this Warrant Agreement and the Warrants in any manner that the Company may deem
to be necessary or desirable and that will not adversely affect the interests of the Registered Holders in any material respect. All other
modifications or amendments to this Warrant Agreement, including any amendment to increase the Warrant Price or shorten the Exercise Period,
shall require the written consent of the Registered Holders of a majority of the then outstanding Public Warrants, and with respect to
any amendment to the terms of only the Private Warrants, shall require the vote or written consent of the Registered Holders of a majority
of the then outstanding Private Warrants, as applicable. Notwithstanding the foregoing, the Company may extend the duration of the Exercise
Period in accordance with Section 3.2 without such consent.

 

9.9 Severability. This
Warrant Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the
validity or enforceability of this Warrant Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid
or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Warrant Agreement a provision
as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

[SIGNATURE PAGE FOLLOWS]

 

    10

     

    

 

IN WITNESS WHEREOF, this Warrant Agreement has
been duly executed by the parties hereto as of the day and year first above written.

 

	 	CHARDAN NEXTECH ACQUISITION CORP.
	 	 	 	 
	 	By:	 
	 	 	Name:	Jonas Grossman
	 	 	Title: 	Chief Executive Officer
	 	 	 	 
	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY
	 	 	 	 
	 	By:	            
	 	 	Name:	               
	 	 	Title:	 

 

[Signature Page to Warrant Agreement]

 

 

11Exhibit
10.1

 

[●],
2021

Chardan
NexTech Acquisition Corp.

17
State Street, 21st Floor

New
York, NY 10004

 

Chardan
Capital Markets, LLC

17
State Street, 21st Floor

New
York, NY 10004

 

	 	Re:	Initial
    Public Offering

 

Gentlemen:

 

This
letter is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”)
entered into by and between Chardan NexTech Acquisition Corp., a Delaware corporation (the “Company”) and Chardan
Capital Markets, LLC, as representative (the “Representative”) of the Underwriters named in Schedule A thereto
(the “Underwriters”), relating to an underwritten initial public offering (the “IPO”)
of the Company’s units (the “Units”), each comprised of one share of Common Stock of the Company, par
value $0.0001 per share (the “Common Stock”), and one warrant, with each warrant being exercisable to purchase
one share of Common Stock at a price of $11.50 per share (“Warrant”). Certain capitalized terms used herein
are defined in paragraph 15 hereof.

 

In
order to induce the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the IPO, and in recognition
of the benefit that such IPO will confer upon each of the undersigned as a stockholder of the Company, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, each of Chardan NexTech Investments LLC (the “Sponsor”),
Chardan NexTech Warrant Holdings LLC (“Holdings”) and the undersigned individuals, each of whom is a member
of the Company’s board of directors and/or management team, hereby agrees with the Company as follows:

 

1.
The officers and directors of the Company will not enter into a binding agreement for a proposed Business Combination or propose any
Business Combination to shareholders of the Company, unless such action is first approved by the Sponsor.

 

2.
Subject to paragraph 1 hereof, if the Company solicits approval of its stockholders of a Business Combination, each of the Insiders will
vote all shares of Common Stock beneficially owned by him, her or it, whether acquired before, in or after the IPO, in favor of such
Business Combination.

 

3.
(a) In the event that the Company fails to consummate a Business Combination within 15 months from the closing of the Company’s
IPO (or up to 21 months from the closing of the IPO if such date is extended as described in the prospectus relating to the IPO), each
of the Insiders shall take all reasonable steps to (i) cause the Trust Fund to be liquidated and distributed to the holders of IPO Shares
and (ii) cause the Company to liquidate promptly as reasonably possible but not more than five business days after the date we are required
to consummate a Business Combination.

 

(b)
Each of the undersigned hereby waives any and all right, title, interest or claim of any kind in or to any distribution of the Trust
Fund and any remaining net assets of the Company as a result of such liquidation with respect to his, her or its Insider Shares, Private
Warrants (and the underlying Common Stock) (“Claim”) and hereby waives any Claim such undersigned may have
in the future as a result of, or arising out of, any contracts or agreements with the Company and will not seek recourse against the
Trust Fund for any reason whatsoever. Each of the undersigned acknowledges and agrees that there will be no distribution from the Trust
Fund with respect to any Common Stock underlying the Private Warrants, all rights of which will terminate on the Company’s liquidation.

 

(c)
In the event of the liquidation of the Trust Fund, the Sponsor agrees to indemnify and hold harmless the Company against any and all
loss, liability, claims, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably
incurred in investigating, preparing or defending against any litigation, whether pending or threatened, or any claim whatsoever) which
the Company may become subject as a result of any claim by any vendor or other person who is owed money by the Company for services rendered
or products sold or contracted for, but only to the extent necessary to ensure that such loss, liability, claim, damage or expense does
not reduce the amount of funds in the Trust Fund; provided, that such indemnity shall not apply if such vendor or other person
has executed an agreement waiving any claims against the Trust Fund.

 

     

     

    

 

(d)
In the event that the Company does not consummate a Business Combination and must liquidate and its remaining net assets are insufficient
to complete such liquidation, each of the undersigned officers and directors agree to advance such funds necessary to complete such liquidation
and agrees not to seek repayment for such expenses.

 

4.
Each of the undersigned will place into escrow all of his, her or its Insider Shares held by the undersigned pursuant to the terms of
a Stock Escrow Agreement that the Company will enter into with each of the undersigned, as applicable, and an escrow agent acceptable
to the Company. 50% of such Insider Shares shall not be transferred, assigned, sold, or released from escrow until the earlier of (a)
six months after the date of the consummation of the Business Combination or (b) the date on which the closing price of the shares of
Common Stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations)
for any 10 trading days within any 30-trading day period commencing after our Business Combination. The remaining 50% of the Insider
Shares will not be transferred, assigned, sold or released from escrow until six months after the date of Business Combination or earlier,
in either case, if, subsequent to our Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange
or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of Common
Stock for cash, securities or other property.

 

5.
Holdings agrees that until the Company consummates a Business Combination, the Private Warrants held by Holdings will be subject to the
transfer restrictions described in the Subscription Agreement relating to the Private Warrants. held by Holdings. Holdings shall not
sell, transfer, assign, pledge or hypothecate any of the Private Warrants issuable to Holdings pursuant to the Private Warrant Purchase
Agreement or shares of Common Stock issuable upon the exercise of the Private Warrants pursuant to the Private Warrant Purchase Agreement,
or subject any of such securities to any hedging, short sale, derivative, put, or call transaction that would result in the effective
economic disposition of such securities, except as provided in FINRA Rule 5110(e)(2).

 

6.
In order to minimize potential conflicts of interest which may arise from multiple affiliations, each of the undersigned officers and
directors (other than independent directors) agrees to present to the Company for its consideration, prior to presentation to any other
person or entity, any suitable opportunity to acquire a target business, until the earlier of the consummation by the Company of a Business
Combination or the liquidation of the Company, subject to any pre-existing fiduciary and contractual obligations such undersigned officer
or non-independent director might have.

 

7.
Subject to paragraph 1 hereof, each of the Insiders acknowledges and agrees that prior to entering into a Business Combination with a
target business that is affiliated with any Insiders of the Company or their affiliates, including any company that is a portfolio company
of, or otherwise affiliated with, or has received financial investment from, an entity with which any Insider or their affiliates is
affiliated, such transaction must be approved by a majority of the Company’s disinterested independent directors and the Company
must obtain an opinion from an independent investment banking firm that such Business Combination is fair to the Company’s unaffiliated
stockholders from a financial point of view.

 

8.
None of the Insiders, nor any respective family member of the Insiders, nor any respective affiliate of the Insiders will be entitled
to receive and will not accept any compensation or other cash payment prior to, or for services rendered in connection with, the consummation
of the Business Combination, except as disclosed in the Registration Statement. Notwithstanding the foregoing, the undersigned and any
affiliate of the undersigned shall be entitled to reimbursement from the Company for their out-of-pocket expenses incurred in connection
with identifying, investigating and consummating a Business Combination.

 

9.
None of the undersigned officers or directors, nor any respective family member of the undersigned officers or directors, nor any respective
affiliate of the undersigned officers or directors will be entitled to receive or accept a finder’s fee or any other compensation
in the event any of the undersigned officers or directors, any respective family member of the undersigned officers or directors or any
respective affiliate of the undersigned officers or directors originates a Business Combination.

 

    2

     

    

 

10.
Each undersigned director/officer agrees to serve the Company in his/her duly appointed role as a director/officer until the earlier
of the consummation by the Company of a Business Combination or the liquidation of the Company. Each undersigned director/officer’s
biographical information previously furnished to the Company and the Representative is true and accurate in all material respects, does
not omit any material information with respect to such undersigned director/officer’s biography and contains all of the information
required to be disclosed pursuant to Item 401 of Regulation S-K, promulgated under the Securities Act of 1933. Each undersigned director/officer’s
FINRA Questionnaire and Director and Officer Questionnaire previously furnished to the Company and the Representative is true and accurate
in all material respects. Each undersigned director/officer represents and warrants that, except as disclosed in such undersigned director/officer’s
Director and Officer Questionnaire:

 

	 	(a)	he/she/it has never had a petition under the federal
    bankruptcy laws or any state insolvency law been filed by or against (i) him/her/it or any partnership in which he/she/it was a general
    partner at or within two years before the time of filing; or (ii) any corporation or business association of which he/she/it was
    an executive officer at or within two years before the time of such filing;
	 	 	 
	 	(b)	he/she/it has never had
    a receiver, fiscal agent or similar officer been appointed by a court for his/her/its business or property, or any such partnership;

 

	 	(c)	he/she/it has never been
    convicted of fraud in a civil or criminal proceeding;

 

	 	(d)	he/she/it/ has never been
    convicted in a criminal proceeding or named the subject of a pending criminal proceeding (excluding traffic violations and minor
    offenses);

 

	 	(e)	he/she/it has never been
    the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction,
    permanently or temporarily enjoining or otherwise limiting him/her/it from (i) acting as a futures commission merchant, introducing
    broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated
    by the Commodity Futures Trading Commission (“CFTC”) or an associated person of any of the foregoing, or as an investment
    adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company,
    bank, savings and loan association or insurance company, or from engaging in or continuing any conduct or practice in connection
    with any such activity; or (ii) engaging in any type of business practice; or (iii) engaging in any activity in connection with the
    purchase or sale of any security or commodity or in connection with any violation of federal or state securities or federal commodities
    laws;

 

	 	(f)	he/she/it has never been
    the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any federal or state authority
    barring, suspending or otherwise limiting for more than 60 days his/her/its right to engage in any activity described in 9(e)(i)
    above, or to be associated with persons engaged in any such activity;

 

	 	(g)	he/she/it has never been
    found by a court of competent jurisdiction in a civil action or by the SEC to have violated any federal or state securities law,
    where the judgment in such civil action or finding by the SEC has not been subsequently reversed, suspended or vacated;
	 	(h)	he/she/it has never been
    found by a court of competent jurisdiction in a civil action or by the CFTC to have violated any federal commodities law, where the
    judgment in such civil action or finding by the CFTC has not been subsequently reversed, suspended or vacated;

 

	 	(i)	he/she/it has never been
    the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree or finding, not subsequently
    reversed, suspended or vacated, relating to an alleged violation of (i) any Federal or State securities or commodities law or regulation,
    (ii) any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or
    permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and desist order,
    or removal or prohibition order or (iii) any law or regulation prohibiting mail or wire fraud or fraud in connection with any business
    entity;

 

    3

     

    

 

	 	(j)	he/she/it has never been
    the subject of, or party to, any sanction or order, not subsequently reversed, suspended or vacated, or any self-regulatory organization,
    any registered entity, or any equivalent exchange, association, entity or organization that has disciplinary authority over its members
    or persons associated with a member;

 

	 	(k)	he/she/it has never been
    convicted of any felony or misdemeanor: (i) in connection with the purchase or sale of any security; (ii) involving the making of
    any false filing with the SEC; or (iii) arising out of the conduct of the business of an underwriter, broker, dealer, municipal securities
    dealer, investment advisor or paid solicitor of purchasers of securities;

 

	 	(l)	he/she/it was never subject
    to a final order of a state securities commission (or an agency of officer of a state performing like functions); a state authority
    that supervises or examines banks, savings associations, or credit unions; a state insurance commission (or an agency or officer
    of a state performing like functions); an appropriate federal banking agency; the CFTC; or the National Credit Union Administration
    that is based on a violation of any law or regulation that prohibits fraudulent, manipulative, or deceptive conduct;

 

	 	(m)	he/she/it has never been
    subject to any order, judgment or decree of any court of competent jurisdiction, that, at the time of such sale, restrained or enjoined
    him/her/it from engaging or continuing to engage in any conduct or practice: (i) in connection with the purchase or sale of any security;
    (ii) involving the making of any false filing with the SEC; or (iii) arising out of the conduct of the business of an underwriter,
    broker, dealer, municipal securities dealer, investment adviser or paid solicitor of purchasers of securities;
	 	 	 
	 	(n)	he/she/it has never been
    subject to any order of the SEC that orders him/her/it to cease and desist from committing or causing a future violation of: (i)
    any scienter-based anti-fraud provision of the federal securities laws, including, but not limited to, Section 17(a)(1) of the Securities
    Act, Section 10(b) of the Exchange Act and Rule 10b-5 thereunder, and Section 206(1) of the Advisers Act or any other rule or regulation
    thereunder; or (ii) Section 5 of the Securities Act;

 

	 	(o)	he/she/it has never been
    named as an underwriter in any registration statement or Regulation A offering statement filed with the SEC that was the subject
    of a refusal order, stop order, or order suspending the Regulation A exemption, or is, currently, the subject of an investigation
    or proceeding to determine whether a stop order or suspension order should be issued;

 

	 	(p)	he/she/it has never been
    subject to a United States Postal Service false representation order, or is currently subject to a temporary restraining order or
    preliminary injunction with respect to conduct alleged by the United States Postal Service to constitute a scheme or device for obtaining
    money or property through the mail by means of false representations;

 

    4

     

    

 

	 	(q)	he/she/it is not subject
    to a final order of a state securities commission (or an agency of officer of a state performing like functions); a state authority
    that supervises or examines banks, savings associations, or credit unions; a state insurance commission (or an agency or officer
    of a state performing like functions); an appropriate federal banking agency; the CFTC; or the National Credit Union Administration
    that bars the undersigned from: (i) association with an entity regulated by such commission, authority, agency or officer; (ii) engaging
    in the business of securities, insurance or banking; or (iii) engaging in savings association or credit union activities;

 

	 	(r)	he/she/it is not subject
    to an order of the SEC entered pursuant to Section 15(b) or 15B(c) of the Securities Exchange Act of 1934 (the “Exchange Act”)
    or Section 203(e) or 203(f) of the Investment Advisers Act of 1940 (the “Advisers Act”) that: (i) suspends or revokes
    the undersigned’s registration as a broker, dealer, municipal securities dealer or investment adviser; (ii) places limitations
    on the activities, functions or operations of, or imposes civil money penalties on, such person; or (iii) bars the undersigned from
    being associated with any entity or from participating in the offering of any penny stock; and
	 	(s)	he/she/it has never been
    suspended or expelled from membership in, or suspended or barred from association with a member of, a securities self-regulatory
    organization (e.g., a registered national securities exchange or a registered national or affiliated securities association) for
    any act or omission to act constituting conduct inconsistent with just and equitable principles of trade.

 

11.
Each undersigned director/officer has full right and power, without violating any agreement by which he is bound, to enter into this
letter agreement and to serve in his/her designated capacity of the Company, as described in the prospectus relating to the IPO).

 

12.
Each of the undersigned hereby waives his, her or its right to exercise conversion rights with respect to any shares of Common Stock
owned or to be owned by him, her, or it, directly or indirectly, whether purchased by him, her, or it prior to the IPO, in the IPO or
in the aftermarket, and agrees that he, she or it will not seek conversion with respect to or otherwise sell, such shares in connection
with any vote to approve a Business Combination with respect thereto, a vote to amend the provisions of the Company’s Amended and
Restated Certificate of Incorporation, or a tender offer by the Company prior to a Business Combination.

 

13.
Each of the undersigned Insiders hereby agrees to not propose, or vote in favor of, an amendment to the Company’s Amended and Restated
Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem the IPO Shares if
the Company cannot complete an initial business combination within 15 months (or up to 21 months from the closing of the IPO if such
date is extended as described in the prospectus relating to the IPO) unless the Company offers holders of IPO Shares the right to receive
their pro rata portion of the funds then held in the Trust Fund upon approval of any such amendment.

 

14.
In connection with Section 5-1401 of the General Obligations Law of the State of New York, this letter agreement shall be governed by,
and construed in accordance with, the laws of the State of New York without regard to principles of conflicts of law that would result
in the application of the substantive law of another jurisdiction. The parties hereto agree that any action, proceeding or claim arising
out of or relating in any way to this letter agreement shall be resolved through final and binding arbitration in accordance with the
International Arbitration Rules of the American Arbitration Association (“AAA”). The arbitration shall be brought before
the AAA International Center for Dispute Resolution’s offices in New York City, New York, will be conducted in English and will
be decided by a panel of three arbitrators selected from the AAA Commercial Disputes Panel and that the arbitrator panel’s decision
shall be final and enforceable by any court having jurisdiction over the party from whom enforcement is sought. The cost of such arbitrators
and arbitration services, together with the prevailing party’s legal fees and expenses, shall be borne by the non-prevailing party
or as otherwise directed by the arbitrators.

 

    5

     

    

 

15.
As used herein, (i) a “Business Combination” shall mean a merger, share exchange, asset acquisition, stock
purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities; (ii) “Insiders”
shall mean all officers, directors and stockholders of the Company immediately prior to the IPO; (iii) “Insider Shares”
shall include all of the shares of Common Stock of the Company acquired by an Insider prior to the IPO and the purchase of the Private
Warrants; (iv) “IPO Shares” shall mean the shares of Common Stock issued in the Company’s IPO; (v) “Private
Warrants” shall mean the warrants (and the underlying securities) purchased in the private placement taking place simultaneously
with the consummation of the Company’s IPO; (vi) “Private Warrant Purchase Agreement” shall mean that
certain Private Warrant Purchase Agreement by and between the Company and Holdings to be executed in connection with the IPO; (vii) “Registration
Statement” means the registration statement on Form S-1 filed by the Company with respect to the IPO; and (viii) “Trust
Fund” shall mean the trust fund into which a portion of the net proceeds of the Company’s IPO will be deposited.

 

16.
Any notice, consent or request to be given in connection with any of the terms or provisions of this letter agreement shall be in writing
and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery
or facsimile transmission.

 

If
to the Representative:

 

Chardan
Capital Markets, LLC

17
State Street

New
York, NY 10004

Attn:
George Kaufman

Facsimile:
(646) 465-9039

 

Copy
(which copy shall not constitute notice) to:

 

Greenberg
Traurig, LLP

200
Park Avenue

New
York, NY 10166

Attn:
Jason T. Simon, Esq.

Facsimile:
(212) 806-6400

 

If
to the Company:

 

Chardan
NexTech Acquisition Corp.

17
State Street, Suite 1600

New
York, NY 10004

Attn:
Jonas Grossman

 

Copy
(which copy shall not constitute notice) to:

 

Reed
Smith LLP

599
Lexington Avenue

New
York, NY 10022

Attn:
Ari Edelman, Esq.

Facsimile:
(212) 521-5450

 

17.
No party hereto may assign either this letter agreement or any of its rights, interests, or obligations hereunder without the prior written
consent of the other party. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate
to transfer or assign any interest or title to the purported assignee. This letter agreement shall be binding on the parties hereto and
any successors and assigns thereof.

 

18.
Each of the undersigned acknowledges and understands that the Underwriters and the Company will rely upon the agreements, representations
and warranties set forth herein in proceeding with the IPO. Nothing contained herein shall be deemed to render the Underwriters a representative
of, or a fiduciary with respect to, the Company, its stockholders or any creditor or vendor of the company with respect to the subject
matter hereof.

 

[Signature
page to follow]

 

    6

     

    

 

	 	Print
    Name of Insider
	 	 
	 	 
	 	Signature

 

[Signature
page to Insider Letter]

 

 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}]]